Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
---|---|---|---|---|---|---|
Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
IOL CHEMICALS & PHARMACEUTICAL | 5273.7 | 205.5 | 5233 | 3.50 | 2,003 | 20.6 |
Bajaj Healthcare Limited | 1251.66 | 117.21 | 1227.94 | 4.65 | 1989 | 45.6 |
PANACEA BIOTEC LTD. | 1117.5 | 96.5 | 1084.3 | 1.58 | 1985 |
IOL Chemicals & Pharmaceuticals Ltd, with Security Code 524164, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Sales | 541.4 | 523.4 | 587.2 | 563.1 | 545.3 | 520.3 | 503.9 | 502.3 | 525.7 | 523.3 |
Expenses | 509.7 | 480.4 | 491.4 | 490.3 | 481.2 | 475.9 | 453.8 | 451.6 | 484.2 | 476.4 |
Operating Profit | 31.7 | 43.0 | 95.8 | 72.9 | 64.1 | 44.5 | 50.1 | 50.8 | 41.6 | 46.9 |
OPM % | 5.85% | 8.22% | 16.31% | 12.94% | 11.75% | 8.55% | 9.94% | 10.11% | 7.9% | 8.96% |
Other Income | 5.1 | 6.6 | 8.7 | 7.1 | 7.1 | 8.4 | 7.5 | 7.4 | 6.4 | 4.1 |
Interest | 3.5 | 4.7 | 4.9 | 4.0 | 4.4 | 4.3 | 3.4 | 2.2 | 4.1 | 4.5 |
Depreciation | 11.3 | 11.7 | 12.1 | 14.4 | 15.7 | 16.3 | 16.4 | 16.8 | 17.9 | 18.7 |
Profit before tax | 21.9 | 33.3 | 87.5 | 61.5 | 51.1 | 32.2 | 37.8 | 39.2 | 25.9 | 27.8 |
Tax % | 28.4% | 27.4% | 25.4% | 24.9% | 26% | 27.9% | 25.4% | 24.3% | 26.2% | 26.1% |
Net Profit | 15.7 | 24.2 | 65.3 | 46.2 | 37.8 | 23.2 | 28.2 | 29.7 | 19.2 | 20.6 |
EPS in Rs | 2.67 | 4.12 | 11.11 | 7.87 | 6.44 | 3.96 | 4.8 | 5.06 | 3.26 | 3.5 |
Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Sales | 565.0 | 541.4 | 523.5 | 587.2 | 563.2 | 545.3 | 520.4 | 503.9 | 502.4 | 525.8 |
Expenses | 509.2 | 509.5 | 480.8 | 491.9 | 490.7 | 481.1 | 476.0 | 454.4 | 451.3 | 484.2 |
Operating Profit | 55.8 | 31.9 | 42.7 | 95.3 | 72.5 | 64.2 | 44.4 | 49.5 | 51.1 | 41.6 |
OPM % | 9.9% | 5.9% | 8.2% | 16.2% | 12.9% | 11.8% | 8.5% | 9.8% | 10.2% | 7.9% |
Other Income | 5.2 | 5.1 | 6.7 | 8.7 | 7.1 | 7.1 | 8.4 | 7.5 | 7.4 | 6.4 |
Interest | 3.4 | 3.5 | 4.7 | 4.9 | 4.0 | 4.4 | 4.3 | 3.4 | 2.2 | 4.1 |
Depreciation | 11.0 | 11.3 | 11.8 | 12.1 | 14.5 | 15.7 | 16.3 | 16.4 | 16.8 | 17.9 |
Profit before tax | 46.6 | 22.1 | 32.9 | 87.0 | 61.2 | 51.2 | 32.1 | 37.2 | 39.5 | 25.9 |
Tax % | 25.6% | 28.1% | 27.7% | 25.6% | 25% | 26% | 28.1% | 25.8% | 24.2% | 26.2% |
Net Profit | 34.7 | 15.9 | 23.8 | 64.8 | 45.9 | 37.9 | 23.1 | 27.6 | 30.0 | 19.2 |
EPS in Rs | 5 | 2 | 4 | 11 | 7 | 6 | 3 | 4 | 5 | 3 |
Compounded Sales Growth | |
---|---|
10 Years: | 14% |
5 Years: | 5% |
3 Years: | 3% |
TTM: | -7% |
Compounded Profit Growth | |
---|---|
10 Years: | 45% |
5 Years: | -11% |
3 Years: | -33% |
TTM: | -43% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 6% |
3 Years: | -3% |
1 Year: | -18% |
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | -7% |
Compounded Profit Growth | |
---|---|
10 Years: | 0% |
5 Years: | 0% |
3 Years: | 0% |
TTM: | -43% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 6% |
3 Years: | -3% |
1 Year: | -18% |
Recent Bets
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
---|